Annual report pursuant to Section 13 and 15(d)

Segment information (Tables)

Segment information (Tables)

12 Months Ended

Jun. 30, 2011

Financial Information Relating to Operating Segments

Following is financial information relating to the operating segments (in thousands):


	Year Ended June 30,
	2011			2010			2009
External sales
Biotechnology	$	270,287		$	250,653		$	246,454
Hematology		19,675			18,394			17,502

Consolidated net sales	$	289,962		$	269,047		$	263,956

Earnings before taxes
Biotechnology	$	164,332		$	155,989		$	156,039
Hematology		7,222			6,869			6,143

Segment earnings before taxes		171,554			162,858			162,182
Other		(6,573	)		(6,412	)		(6,819	)

Consolidated earnings before taxes	$	164,981		$	156,446		$	155,363

Goodwill
Biotechnology	$	86,633		$	25,068		$	25,068
Hematology		0			0			0

Consolidated goodwill	$	86,633		$	25,068		$	25,068

Intangible assets, net
Biotechnology	$	52,282		$	2,044		$	3,004
Hematology		0			0			0

Consolidated intangible assets, net	$	52,282		$	2,044		$	3,004

Assets
Biotechnology	$	505,087		$	400,112		$	355,445
Hematology		21,046			18,543			15,804

Segment assets		526,133			418,655			371,249
Other		91,537			100,161			100,756

Consolidated assets	$	617,670		$	518,816		$	472,005

Depreciation and amortization
Biotechnology	$	7,165		$	5,411		$	4,502
Hematology		417			340			229

Segment depreciation and amortization		7,582			5,751			4,731
Other		1,118			2,379			3,035

Consolidated depreciation and amortization	$	8,700		$	8,130		$	7,766

Capital purchases
Biotechnology	$	2,707		$	3,885		$	3,501
Hematology		149			208			94

Segment capital purchases		2,856			4,093			3,595
Other		774			551			2,961

Consolidated capital purchases	$	3,630		$	4,644		$	6,556

Financial Information Relating to Geographic Areas

Following is financial information relating to geographic areas (in thousands):


	Year Ended June 30,
	2011		2010		2009
External sales
United States	$	159,857	$	148,137	$	147,271
Europe		83,676		78,496		79,381
China		8,299		6,792		5,645
Other		38,130		35,622		31,659

Total external sales	$	289,962	$	269,047	$	263,956

Long-lived assets
United States	$	88,802	$	91,554	$	93,571

Europe		7,819		6,299		7,214
China		96		70		98

Total long-lived assets	$	96,717	$	97,923	$	100,883

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References + Details

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details